1. CHALLENGES IN CONTRACEPTIVE PROCUREMENT Manondo Msefula, Logistics Advisor, USAID | DELIVER

2. Current Situation - 1 MMR high at 807 deaths out of 100,000 births FP one way of addressing maternal mortality CBD program creating demand for FP in communities where most women live through: –Provision of OC and Condoms by CBDAs –Provision of Injectables by HSAs

3. Current Situation - 2 Consumption trends showing higher preference for injectables and implants than other methods Donated DMPA costing districts 5% of cost as warehousing and handling fee to CMS SWAp funded DMPA costing districts 12.5% -Limiting factor in quantities procured by districts -Limiting factor in client access to method of choice

4. The Role of JSI Support implementation of FP intervention through the –Procurement of Oral Contraceptives, Implants and IUDs –Design and implementation of integrated distribution systems [working with HTSS Dept in MoH] –Building human capacity at CMS, RMS and SDP in logistics management

5. Challenges Funding for Contraceptive Procurement at Central Level –Not enough funding being allocated to procurement of contraceptives - Currently gaps exist for procurement of DMPA and Condoms - Based on quantification results –Long lead times

6. Challenges Procurement Policy for DMPA at District Level –DHOs prioritizing curative drugs because SWAp funded DMPA is costly –DHOs procuring less than required and rationing DMPA – CHAM facilities suffering –Facilities rationing DMPA to HSAs –Stockouts of DMPA at facility and community level

7. Proposals Procurement of OCs Injectables and Implants –Development partners to take up Injectables, IUDs and Implants –SWAp to take up OCs and Condoms

8. Proposals Warehousing and Distribution Fees –Funds to be identified for paying CMS’ fees for warehousing and distribution CHAM facilities and their clients benefit

9. In Conclusion Procurement of adequate contraceptive stocks is crucial to the success of the family planning

10. Why? No product? No program.

11. Thank You!